Enhancing Aseptic Inflammation Resolution with 1-(2-Ethoxyethyl)-4-(pent-1-yn-1-yl)piperidin-4-yl Propionate: A Novel β-Cyclodextrin Complex as a Therapeutic Agent.
Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
12 authors.
Symbat ZhumakovaLaboratory of Synthetic and Natural Medicinal Compounds Chemistry, A.B. Bekturov Institute of Chemical Sciences, 106 Sh. Ualikhanov St., Almaty 050010, Kazakhstan.ORCID 0000-0002-4129-6931
Aliya TokushevaDepartment of Pathological Physiology, Asfendiyarov Kazakh National Medical University, 94 Tole-bi St., Almaty 050000, Kazakhstan.
Tolganay ZharkynbekLaboratory of Synthetic and Natural Medicinal Compounds Chemistry, A.B. Bekturov Institute of Chemical Sciences, 106 Sh. Ualikhanov St., Almaty 050010, Kazakhstan.ORCID 0000-0001-8884-5646
Marina BalabekovaDepartment of Pathological Physiology, Asfendiyarov Kazakh National Medical University, 94 Tole-bi St., Almaty 050000, Kazakhstan.
Sulev KoksHealth Futures Institute, Murdoch University, 90 South St., Perth, WA 6150, Australia.
Tulegen SeilkhanovLaboratory of Engineering Profile of NMR Spectroscopy, Sh. Ualikhanov Kokshetau State University, 76 Abai St., Kokshetau 020000, Kazakhstan.ORCID 0000-0003-0079-4755
Valery DembitskyCentre for Applied Research, Innovation and Entrepreneurship, Lethbridge College, 3000 College Drive South, Lethbridge, AB T1K 1L6, Canada.ORCID 0000-0002-4603-8704
Alexey ZazybinSchool of Chemical Engineering, Kazakh-British Technical University, 59 Tole bi St., Almaty 050000, Kazakhstan.
Murat AydemirDepartment of Chemistry, Faculty of Science, Dicle University, Diyarbakir 21280, Turkey.
Ulan KemelbekovLaboratory of Synthetic and Natural Medicinal Compounds Chemistry, A.B. Bekturov Institute of Chemical Sciences, 106 Sh. Ualikhanov St., Almaty 050010, Kazakhstan.ORCID 0000-0002-2537-1559
Gulgul KairanbayevaDepartment of Pathological Physiology, Asfendiyarov Kazakh National Medical University, 94 Tole-bi St., Almaty 050000, Kazakhstan.ORCID 0000-0001-9337-7728
Valentina YuLaboratory of Synthetic and Natural Medicinal Compounds Chemistry, A.B. Bekturov Institute of Chemical Sciences, 106 Sh. Ualikhanov St., Almaty 050010, Kazakhstan.ORCID 0000-0001-6508-707X
Funding
Ministry of Science and Higher Education of the Republic of Kazakhstan AP19676539
6 · The paper itself
Abstract
The synthesized compound, 1-(2-ethoxyethyl)-4-(pent-1-yn-1-yl)piperidin-4-yl propionate (
Indexed as
beta-CyclodextrinsInflammationT-Lymphocytes, RegulatoryAnimalsAnti-Inflammatory AgentsCell ProliferationMalePiperidinesPropionatesRatsAnti-Inflammatory Agentsbeta-CyclodextrinsbetadexPiperidinesPropionates1-(2-ethoxyethyl)-4-(pent-1-yn-1-yl)piperidin-4-yl propionate (EPPP)ammonium vanadate (NH4VO3)aseptic inflammationcomplex EPPP with β-cyclodextrin (EPPPβCD)heavy metal technology-related exposurepotassium bichromate (K2Cr2O7)supracomplex
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Enhancing Aseptic Inflammation Resolution with 1-(2-Ethoxyethyl)-4-(pent-1-yn-1-yl)piperidin-4-yl Propionate: A Novel β-Cyclodextrin Complex as a Therapeutic Agent. · full record | OpenQuestion